Perspectives in Drug Discovery and Design

, Volume 5, Issue 1, pp 225–233 | Cite as

Suramin: A polysulfonated compound that inhibits the binding of HIV-1 gp120 to GalCer/sulfatide and blocks the CD4-independent pathway of HIV-1 infection in mucosal epithelial cells

  • Djilali Hammache
  • Olivier Delézay
  • Jacques Fantini
  • Nouara Yahi
Part VII. Inhibition Of HIV Entry Into CD4− Cells


Infection of human colonic epithelial HT-29 cells by human immunodeficiency virus type 1 (HIV-1) occurs independently of CD4, the main HIV-1 receptor expressed on lymphocytes and macrophages. Recent studies by our group have shown that HT-29 cells express the glycosphingolipid galactosylceramide (GalCer), a potential alternative receptor for the HIV-1 envelope glycoprotein gp120. The binding of recombinant gp120 to GalCer is blocked by monoclonal antibodies directed against the third variable region (V3) of gp120, suggesting that the V3 domain is implicated in GalCer recognition. The interaction between GalCer and the V3 loop of gp120 is specifically inhibited by suramin, a polysulfonated naphthylurea previously characterized as an inhibitor of retroviral reverse transcriptases. The biochemical and virological data presented in this report show that suramin is a competitive inhibitor of the GalCer-dependent pathway of HIV-1 infection in HT-29 cells.


Suramin Mucosal Epithelial Cell Envelope Glycoprotein Gp120 Recombinant Gp120 Naphthylurea 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Mayer, K.H., Ayotte, D., Groopman, J.E., Stoddard, A.M., Sarngadharan, M. and Gallo, R., Am. J. Med., 80 (1987) 357.Google Scholar
  2. 2.
    Smith, P.D. and Mai, U.E.H., Gastroenterol. Clin. North Am., 21 (1992) 331.Google Scholar
  3. 3.
    Amerongen, H.M., Weltzin, R., Farner, C.M., Michetti, P., Haseltine, W.A. and Neutra, M.R., J. Acquired Immune Defic. Syndr., 4 (1991) 760.Google Scholar
  4. 4.
    Tucker, S.P. and Compans, R.W., Adv. Virus Res., 42 (1993) 187.Google Scholar
  5. 5.
    Levy, J.A., Margaretten, W. and Nelson, J., Am. J. Gastroenterol., 84 (1989) 787.Google Scholar
  6. 6.
    Heise, C., Dandekar, S., Kumar, P., Duplantier, R., Donovan, R.M. and Halsted, C.H., Gastroenterology, 100 (1991) 1521.Google Scholar
  7. 7.
    Kotler, D.P., Reka, S., Borcich, A. and Cronin, W.J., Am. J. Pathol., 139 (1991) 823.Google Scholar
  8. 8.
    Adachi, A., Koenig, S., Gendelman, H.E., Daugherty, D., Gattoni-Celli, S., Fauci, A. and Martin, M., J. Virol., 61 (1987) 209.Google Scholar
  9. 9.
    Omary, M.B., Brenner, D.A., de Grandpre, L.Y., Roebuck, K.A., Richman, D.D. and Kagnoff, M.F., Aids, 5 (1991) 275.Google Scholar
  10. 10.
    Barnett, S.W., Barboza, A., Wilcox, C.M., Fosmark, C.E. and Levy, J.A., Virology, 182 (1991) 902.Google Scholar
  11. 11.
    Moyer, M.P. and Gendelman, H.E., J. Leukocyte Biol., 49 (1991) 499.Google Scholar
  12. 12.
    Phillips, D.M. and Bourinbaiar, A.S., Virology, 186 (1992) 261.Google Scholar
  13. 13.
    Yahi, N., Baghdiguian, S., Bolmont, C. and Fantini, J., Eur. J. Immunol., 22 (1992) 2495.Google Scholar
  14. 14.
    Bourinbaiar, A.S. and Nagorny, R., Eur. J. Pharmacol., 230 (1993) 15.Google Scholar
  15. 15.
    Faure, E., Yahi, N., Zider, A., Cavard, C., Champion, S. and Fantini, J., Virus Res., 34 (1994) 1.Google Scholar
  16. 16.
    Yahi, N., Baghdiguian, S., Moreau, H. and Fantini, J., J. Virol., 66 (1992) 4848.Google Scholar
  17. 17.
    Asmuth, D.M., Hammer, S.M. and Wanke, C.A., Aids, 8 (1994) 205.Google Scholar
  18. 18.
    Fantini, J., Cook, D.G., Nathanson, N., Spitalnik, S.L. and Gonzalez-Scarano, F., Proc. Natl. Acad. Sci. USA, 90 (1993) 2700.Google Scholar
  19. 19.
    Bhat, S., Spitalnik, S.L., Gonzalez-Scarano, F. and Silberberg, D.H., Proc. Natl. Acad. Sci. USA, 88 (1991) 7131.Google Scholar
  20. 20.
    Harouse, J.M., Bhat, S., Spitalnik, S.L., Laughlin, M., Stefano, K., Silberberg, D.H. and Gonzalez-Scarano, F., Science, 253 (1991) 320.Google Scholar
  21. 21.
    Harouse, J.M., Collman, R. and Gonzalez-Scarano, F., J. Virol., 69 (1995) 7383.Google Scholar
  22. 22.
    Bjork, S., Breimer, M.E., Hannson, G.C., Karlsson, K.A. and Leffler, H., J. Biol. Chem., 262 (1987) 6758.Google Scholar
  23. 23.
    Holgerson, J., Jovall, P.A. and Breimer, M.E., J. Biochem., 110 (1991) 120.Google Scholar
  24. 24.
    De Clercq, E., Cancer Lett., 8 (1979) 9.Google Scholar
  25. 25.
    Fantini, J., Guo, X.J., Marvaldi, J. and Rougon, G., Int. J. Cancer, 45 (1990) 554.Google Scholar
  26. 26.
    McAlarney, T., Apostolski, S., Lederman, S. and Latov, N., J. Neurosci. Res., 37 (1994) 453.Google Scholar
  27. 27.
    Mitsuya, H., Popovic, M., Yarchoan, R., Matsuhita, S., Gallo, R.C. and Broder, S., Science, 226 (1984) 172.Google Scholar
  28. 28.
    De Clercq, E., Antiviral Res., 7 (1987) 1.Google Scholar
  29. 29.
    Baghdiguian, S., Boudier, J.L., Boudier, J.A. and Fantini, J., Eur. J. Cancer, (1996) in press.Google Scholar
  30. 30.
    Yahi, N., Sabatier, J.M., Nickel, P., Mabrouk, K., Gonzalez-Scarano, F. and Fantini, J., J. Biol. Chem., 269 (1994) 24349.Google Scholar
  31. 31.
    Witvrouw, M., Desmyter, J. and De Clercq, E., Antiviral Chem. Chemother., 5 (1994) 345.Google Scholar
  32. 32.
    Baghdiguian, S., Nickel, P. and Fantini, J., Cancer Lett., 60 (1991) 213.Google Scholar

Copyright information

© ESCOM Science Publishers B.V 1996

Authors and Affiliations

  • Djilali Hammache
    • 1
  • Olivier Delézay
    • 1
  • Jacques Fantini
    • 1
  • Nouara Yahi
    • 1
  1. 1.Faculté de Médecine NordCNRS URA 1455, Institut Fédératif Jean RocheMarseille Cédex 20France

Personalised recommendations